Buscar
BridgeBio Oncology Therapeutics Ord Shs
BBOTAñadir a la lista de seguimiento
3.990USD
-0.170-4.09%
Cierre 09-24 16:00（ET）
319.64MCap. mercado
19.79P/E TTM
Acerca de Compañía
Perfil de BridgeBio Oncology Therapeutics Ord Shs
Símbolo de cotización- -
Nombre de la empresa- -
Fecha de salida a bolsa- -
Director ejecutivo- -
Número de empleados- -
Tipo de seguridad- -
Fin del año fiscal- -
Dirección- -
Ciudad- -
Bolsa de valores- -
País- -
Código postal- -
Teléfono- -
Sitio Web- -
Símbolo de cotización- -
Fecha de salida a bolsa- -
Director ejecutivo- -
Ejecutivos de BridgeBio Oncology Therapeutics Ord Shs
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Idan Elmelech
Mr. Idan Elmelech
Chief Operating Officer, Principal Financial Officer
Chief Operating Officer, Principal Financial Officer
14.49K
-2.37%
Mr. Idan Elmelech
Mr. Idan Elmelech
Chief Operating Officer, Principal Financial Officer
Chief Operating Officer, Principal Financial Officer
14.49K
-2.37%
Mr. Marc Cobo
Mr. Marc Cobo
Vice President - Finance, Controller, Principal Accounting Officer
Vice President - Finance, Controller, Principal Accounting Officer
14.14K
+62.48%
Mr. Marc Cobo
Mr. Marc Cobo
Vice President - Finance, Controller, Principal Accounting Officer
Vice President - Finance, Controller, Principal Accounting Officer
14.14K
+62.48%
,
,
--
--
Mr. Pedro J. Beltran, Ph.D.
Mr. Pedro J. Beltran, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Ben (Ben) Yong, M.D.
Mr. Ben (Ben) Yong, M.D.
Chief Medical and Development Officer
Chief Medical and Development Officer
--
--
Ms. Angela Peters
Ms. Angela Peters
Senior Vice President - People
Senior Vice President - People
--
--
Mr. Wang Bin, Ph.D.
Mr. Wang Bin, Ph.D.
Senior Vice President - Drug Discovery
Senior Vice President - Drug Discovery
--
--
Mr. Daniel Watson, Ph.D.
Mr. Daniel Watson, Ph.D.
Senior Vice President - Chemistry, Manufacturing, and Controls
Senior Vice President - Chemistry, Manufacturing, and Controls
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Idan Elmelech
Mr. Idan Elmelech
Chief Operating Officer, Principal Financial Officer
Chief Operating Officer, Principal Financial Officer
14.49K
-2.37%
Mr. Idan Elmelech
Mr. Idan Elmelech
Chief Operating Officer, Principal Financial Officer
Chief Operating Officer, Principal Financial Officer
14.49K
-2.37%
Mr. Marc Cobo
Mr. Marc Cobo
Vice President - Finance, Controller, Principal Accounting Officer
Vice President - Finance, Controller, Principal Accounting Officer
14.14K
+62.48%
Mr. Marc Cobo
Mr. Marc Cobo
Vice President - Finance, Controller, Principal Accounting Officer
Vice President - Finance, Controller, Principal Accounting Officer
14.14K
+62.48%
,
,
--
--
Mr. Pedro J. Beltran, Ph.D.
Mr. Pedro J. Beltran, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de BridgeBio Oncology Therapeutics Ord Shs?
Los cinco principales accionistas de BridgeBio Oncology Therapeutics Ord Shs son: Mr. Idan Elmelech